Abstract
The 9th Unilever Nutrition Symposium entitled ‘Essential fats for future health’, held on 26–27 May 2010, aimed to review the dietary recommendations for essential fatty acids (EFA); discuss the scientific evidence for the roles of EFA in cognition, immune function and cardiovascular health; and to identify opportunities for joint efforts by industry, academia, governmental and non-governmental organizations to effectively improve health behaviour. This paper summarizes the main conclusions of the presentations given at the symposium. Linoleic acid (LA) and α-linolenic acid (ALA) are EFA that cannot by synthesized by the human body. Docosahexaenoic acid (DHA) is considered as conditionally essential because of its limited formation from ALA in the human body and its critical role in early normal retinal and brain development and, jointly with eicosapentaenoic acid (EPA), in prevention of cardiovascular disease (CVD). Some evidence for possible beneficial roles of n-3 fatty acids for immune function and adult cognitive function is emerging. A higher consumption of polyunsaturated fatty acids (PUFA; >10%E), including LA, ALA and at least 250–500 mg per day of EPA+DHA, is recommended for prevention of coronary heart disease (CHD). Two dietary interventions suggest that EFA may affect CVD risk factors in children similarly as in adults. To ensure an adequate EFA intake of the population, including children, public health authorities should develop clear messages based on current science; ensure availability of healthy, palatable foods; and collaborate with scientists, the food industry, schools, hospitals, health-care providers and communities to encourage consumers to make healthy choices.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akerblom HK, Viikari J, Uhari M, Rasanen L, Byckling T, Louhivuori K et al. (1985). Atherosclerosis precursors in Finnish children and adolescents. I. General description of the cross-sectional study of 1980, and an account of the children's and families’ state of health. Acta Paediatr Scand Suppl 318, 49–63.
Albanese E, Dangour AD, Uauy R, Acosta D, Guerra M, Guerra SS et al. (2009). Dietary fish and meat intake and dementia in Latin America, China, and India: A 10/66 Dementia Research Group population-based study. Am J Clin Nutr 90, 392–400.
Albers R, Antoine JM, Bourdet-Sicard R, Calder PC, Gleeson M, Lesourd B et al. (2005). Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr 94, 452–481.
Armstrong R, Doyle J, Lamb C, Waters E (2006). Multi-sectoral health promotion and public health: the role of evidence. J Public Health (Oxf) 28, 168–172.
Barberger-Gateau P, Letenneur L, Deschamps V, Peres K, Dartigues JF, Renaud S (2002). Fish, meat, and risk of dementia: cohort study. BMJ 325, 932–933.
Bazan NG (2006). Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci 29, 263–271.
Berenson GS, Srinivasan SR, Bao W, Newman III WP, Tracy RE, Wattigney WA (1998). Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338, 1650–1656.
Brouwer IA, Katan MB, Zock PL (2004). Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr 134, 919–922.
Brouwer IA, Raitt MH, Dullemeijer C, Kraemer DF, Zock PL, Morris C et al. (2009). Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. Eur Heart J 30, 820–826.
Burdge GC, Calder PC (2006). Dietary alpha-linolenic acid and health-related outcomes: a metabolic perspective. Nutr Res Rev 19, 26–52.
Burr GO, Burr MM (1973). Nutrition classics from the journal of biological chemistry 82:345-67, 1929. A new deficiency disease produced by the rigid exclusion of fat from the diet. Nutr Rev 31, 248–249.
Calder PC (2001). Polyunsaturated fatty acids, inflammation, and immunity. Lipids 36, 1007–1024.
Calder PC (2006). N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83, 1505S–1519S.
Calder PC (2007). Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 77, 327–335.
Calder PC (2008). The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids 79, 101–108.
Calder PC, Albers R, Antoine JM, Blum S, Bourdet-Sicard R, Ferns GA et al. (2009). Inflammatory disease processes and interactions with nutrition. Br J Nutr 101 (Suppl 1), S1–S45.
Calder PC, Yaqoob P, Thies F, Wallace FA, Miles EA (2002). Fatty acids and lymphocyte functions. Br J Nutr 87 (Suppl 1), S31–S48.
Caspi A, Williams B, Kim-Cohen J, Craig IW, Milne BJ, Poulton R et al. (2007). Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism. Proc Natl Acad Sci USA 104, 18860–18865.
Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ (1996). The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63, 116–122.
Cetin I, Koletzko B (2008). Long-chain omega-3 fatty acid supply in pregnancy and lactation. Curr Opin Clin Nutr Metab Care 11, 297–302.
Chen X, Wang Y (2008). Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation 117, 3171–3180.
Cole GM, Frautschy SA (2010). DHA may prevent age-related dementia. J Nutr 140, 869–874.
Corvalan C, Uauy R, Kain J, Martorell R (2010). Obesity indicators and cardiometabolic status in 4-y-old children. Am J Clin Nutr 91, 166–174.
Cummings JH, Antoine JM, Azpiroz F, Bourdet-Sicard R, Brandtzaeg P, Calder PC et al. (2004). PASSCLAIM—gut health and immunity. Eur J Nutr 43 (Suppl 2), II118–II173.
Damsgaard CT, Lauritzen L, Kjaer TM, Holm PM, Fruekilde MB, Michaelsen KF et al. (2007). Fish oil supplementation modulates immune function in healthy infants. J Nutr 137, 1031–1036.
Dangour AD, Allen E, Elbourne D, Fasey N, Fletcher AE, Hardy P et al. (2010). Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am J Clin Nutr 91, 1725–1732.
Davis PH, Dawson JD, Riley WA, Lauer RM (2001). Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation 104, 2815–2819.
de Deckere EAM, Verschuren PM (2000). Functional fats and spreads. In: GR Gibson and CM Williams (eds). Functional Foods: Concept to Product. CRC press: Cambridge.
Denburg JA, Hatfield HM, Cyr MM, Hayes L, Holt PG, Sehmi R et al. (2005). Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatr Res 57, 276–281.
Dickinson E, McClements DJ (1996). Advances in Food Colloids. Blackie Academic and Professional: Glasgow.
Diekman C, Malcolm K (2009). Consumer perception and insights on fats and fatty acids: knowledge on the quality of diet fat. Ann Nutr Metab 54 (Suppl 1), 25–32.
Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG et al. (2003a). Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. J Allergy Clin Immunol 112, 1178–1184.
Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG et al. (2003b). Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy. Clin Exp Allergy 33, 442–448.
EFSA Panel on Dietetic Products, Nutrition and Allergies (2010). Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA-Q-2008-466. EFSA J 8, 1461.
Elmadfa I, Kornsteiner M (2009). Dietary fat intake—a global perspective. Ann Nutr Metab 54 (Suppl 1), 8–14.
Fernandez-Real JM, Broch M, Vendrell J, Ricart W (2003). Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care 26, 1362–1368.
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M et al. (2005). Global prevalence of dementia: a delphi consensus study. Lancet 366, 2112–2117.
Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F et al. (2006). Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 91, 439–446.
Ford ES, Li C, Zhao G, Mokdad AH (2009). Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the United States. Circulation 119, 1108–1115.
Galgani JE, Uauy RD, Aguirre CA, Diaz EO (2008). Effect of the dietary fat quality on insulin sensitivity. Br J Nutr 100, 471–479.
Glaser C, Heinrich J, Koletzko B (2010). Role of FADS1 and FADS2 polymorphisms in polyunsaturated fatty acid metabolism. Metabolism 59, 993–999.
Griffin BA (2008). How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study. Curr Opin Lipidol 19, 57–62.
Hansen AE, Wiese HF, Boelsche AN, Haggard ME, Adam DJD, Davis H (1963). Role of linoleic acid in infant nutrition: clinical and chemical study of 428 infants fed on milk mixtures varying in kind and amount of fat. Pediatrics 31, 171–192.
Harbige LS (2003). Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids 38, 323–341.
Harika RK, Cosgrove MC, Osendarp SJ, Verhoef P, Zock PL : Fatty acid intakes of children and adolescents are not in line with the dietary intake recommendations for future cardiovascular health: a review of dietary intake data from 28 countries. (Submitted for publication).
Harris WS, Mozaffarian D, Lefevre M, Toner CD, Colombo J, Cunnane SC et al. (2009a). Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 139, 804S–819S.
Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ et al. (2009b). Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American heart association nutrition subcommittee of the council on nutrition, physical activity, and metabolism; council on cardiovascular nursing; and council on epidemiology and prevention. Circulation 119, 902–907.
Helland IB, Saugstad OD, Smith L, Saarem K, Solvoll K, Ganes T et al. (2001). Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 108, art-e82.
Helland IB, Smith L, Blomen B, Saarem K, Saugstad OD, Drevon CA (2008). Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children's IQ and body mass index at 7 years of age. Pediatrics 122, e472–e479.
Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA (2003). Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 111, art-e39.
Hibbeln JR, Davis JM, Steer C, Emmett P, Rogers I, Williams C et al. (2007). Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 369, 578–585.
Holman RT, Johnson SB, Hatch TF (1982). A case of human linolenic acid deficiency involving neurological abnormalities. Am J Clin Nutr 35, 617–623.
Jakobsen MU, O’Reilly EJ, Heitmann BL, Pereira MA, Balter K, Fraser GE et al. (2009). Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 89, 1425–1432.
Kim W, Khan NA, McMurray DN, Prior IA, Wang N, Chapkin RS (2010). Regulatory activity of polyunsaturated fatty acids in T-cell signaling. Prog Lipid Res 49, 250–261.
Kirby A, Woodward A, Jackson S, Wang Y, Crawford MA (2010). A double-blind, placebo-controlled study investigating the effects of omega-3 supplementation in children aged 8–10 years from a mainstream school population. Res Dev Disabil 31, 718–730.
Koletzko B, Cetin I, Brenna JT (2007). Dietary fat intakes for pregnant and lactating women. Br J Nutr 98, 873–877.
Koletzko B, Lien E, Agostoni C, Bohles H, Campoy C, Cetin I et al. (2008). The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 36, 5–14.
Krauss-Etschmann S, Hartl D, Rzehak P, Heinrich J, Shadid R, Del CR-T et al. (2008). Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women. J Allergy Clin Immunol 121, 464–470.
Kremmyda LS, Vlachava M, Noakes PS, Diaper ND, Miles EA, Calder PC (2009). Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 fatty acids: a systematic review. Clin Rev Allergy Immunol (DOI:10.1007/S21016-009-8186-2).
Lattka E, Illig T, Heinrich J, Koletzko B (2010a). Do FADS genotypes enhance our knowledge about fatty acid related phenotypes? Clin Nutr 29, 277–287.
Lattka E, Illig T, Koletzko B, Heinrich J (2010b). Genetic variants of the FADS1 FADS2 gene cluster as related to essential fatty acid metabolism. Curr Opin Lipidol 21, 64–69.
Li S, Chen W, Srinivasan SR, Berenson GS (2004). Childhood blood pressure as a predictor of arterial stiffness in young adults: the Bogalusa heart study. Hypertension 43, 541–546.
Li S, Chen W, Srinivasan SR, Bond MG, Tang R, Urbina EM et al. (2003). Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa heart study. JAMA 290, 2271–2276.
Lim WS, Gammack JK, Van NJ, Dangour AD (2006). Omega 3 fatty acid for the prevention of dementia. Cochrane Database Syst Rev, CD 005379.
Lomas J (2007). The in-between world of knowledge brokering. BMJ 334, 129–132.
Lopez-Garcia E, Schulze MB, Manson JE, Meigs JB, Albert CM, Rifai N et al. (2004). Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 134, 1806–1811.
Lotfi M, Mannar MGV, Merx RJHM, Naber-Van den Heuvel P (1996). Micronutrient Fortification of Foods. Current Practices, Research, and Opportunities. The Micronutrient Initiative/International Development Research Centre/International Agricultural Centre: Ottawa.
McGill HC, McMahan CA, Zieske AW, Malcom GT, Tracy RE, Strong JP (2001). Effect of nonlipid risk factors on atherosclerosis in youth with favorable lipoprotein profile. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Circulation 103, 1546–1550.
McLennan PL (2001). Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models. Lipids 36 (Suppl), S111–S114.
McNamara RK, Able J, Jandacek R, Rider T, Tso P, Eliassen JC et al. (2010). Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: A placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am J Clin Nutr 91, 1060–1067.
Mensink RP, Zock PL, Kester AD, Katan MB (2003). Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77, 1146–1155.
Mente A, de KL, Shannon HS, Anand SS (2009). A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 169, 659–669.
Merchant AT, Curhan GC, Rimm EB, Willett WC, Fawzi WW (2005). Intake of n-6 and n-3 fatty acids and fish and risk of community-acquired pneumonia in US men. Am J Clin Nutr 82, 668–674.
Morrison JA, Friedman LA, Gray-McGuire C (2007). Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton lipid research clinics follow-up study. Pediatrics 120, 340–345.
Mozaffarian D (2005). Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence. Altern Ther Health Med 11, 24–30.
Mozaffarian D (2007). Fish, n-3 fatty acids, and cardiovascular haemodynamics. J Cardiovasc Med (Hagerstown) 8 (Suppl 1), S23–S26.
Mozaffarian D, Micha R, Wallace S (2010). Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 7, e1000252.
Mozaffarian D, Rimm EB (2006). Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296, 1885–1899.
Niinikoski H, Jula A, Viikari J, Ronnemaa T, Heino P, Lagstrom H et al. (2009). Blood pressure is lower in children and adolescents with a low-saturated-fat diet since infancy: the special turku coronary risk factor intervention project. Hypertension 53, 918–924.
Niinikoski H, Lagstrom H, Jokinen E, Siltala M, Ronnemaa T, Viikari J et al. (2007). Impact of repeated dietary counseling between infancy and 14 years of age on dietary intakes and serum lipids and lipoproteins: the STRIP study. Circulation 116, 1032–1040.
Niinikoski H, Viikari J, Ronnemaa T, Helenius H, Jokinen E, Lapinleimu H et al. (1997). Regulation of growth of 7- to 36-month-old children by energy and fat intake in the prospective, randomized STRIP baby trial. Pediatrics 100, 810–816.
Obarzanek E, Kimm SY, Barton BA, Van Horn LL, Kwiterovich Jr PO, Simons-Morton DG et al. (2001). Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC). Pediatrics 107, 256–264.
Oh K, Hu FB, Manson JE, Stampfer MJ, Willett WC (2005). Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses’ health study. Am J Epidemiol 161, 672–679.
Ohlund I, Hornell A, Lind T, Hernell O (2008). Dietary fat in infancy should be more focused on quality than on quantity. Eur J Clin Nutr 62, 1058–1064.
Osendarp SJ, Baghurst KI, Bryan J, Calvaresi E, Hughes D, Hussaini M et al. (2007). Effect of a 12-mo micronutrient intervention on learning and memory in well-nourished and marginally nourished school-aged children: 2 parallel, randomized, placebo-controlled studies in Australia and Indonesia. Am J Clin Nutr 86, 1082–1093.
Oxman AD, Lavis JN, Lewis S, Fretheim A (2009). Support tools for evidence informed policy making. Health Res Policy Syst 16, S1.
Peoples GE, McLennan PL, Howe PR, Groeller H (2008). Fish oil reduces heart rate and oxygen consumption during exercise. J Cardiovasc Pharmacol 52, 540–547.
Raghuveer G (2010). Lifetime cardiovascular risk of childhood obesity. Am J Clin Nutr 91, 1514S–1519S.
Rask-Nissila L, Jokinen E, Terho P, Tammi A, Lapinleimu H, Ronnemaa T et al. (2000). Neurological development of 5-year-old children receiving a low-saturated fat, low-cholesterol diet since infancy: a randomized controlled trial. JAMA 284, 993–1000.
Riserus U, Willett WC, Hu FB (2009). Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 48, 44–51.
Salem Jr N, Wegher B, Mena P, Uauy R (1996). Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc Natl Acad Sci USA 93, 49–54.
Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R et al. (2006). Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham heart study. Arch Neurol 63, 1545–1550.
Schubert CM, Sun SS, Burns TL, Morrison JA, Huang TT (2009). Predictive ability of childhood metabolic components for adult metabolic syndrome and type 2 diabetes. J Pediatr 155, S6–S7.
Shaikh SR, Edidin M (2006). Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation. Am J Clin Nutr 84, 1277–1289.
Sijben JW, Calder PC (2007). Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease. Proc Nutr Soc 66, 237–259.
Simell O, Niinikoski H, Ronnemaa T, Raitakari OT, Lagstrom H, Laurinen M et al. (2009). Cohort Profile: the STRIP Study (Special Turku Coronary Risk Factor Intervention Project), an Infancy-onset Dietary and Life-style Intervention Trial. Int J Epidemiol 38, 650–655.
Smit LA, Mozaffarian D, Willett W (2009). Review of fat and fatty acid requirements and criteria for developing dietary guidelines. Ann Nutr Metab 55, 44–55.
Tanaka T, Shen J, Abecasis GR, Kisialiou A, Ordovas JM, Guralnik JM et al. (2009). Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet 5, e1000338.
Thienprasert A, Samuhaseneetoo S, Popplestone K, West AL, Miles EA, Calder PC (2009). Fish oil n-3 polyunsaturated fatty acids selectively affect plasma cytokines and decrease illness in Thai schoolchildren: a randomized, double-blind, placebo-controlled intervention trial. J Pediatr 154, 391–395.
Uauy R, Corvalan C, Dangour AD (2009). Conference on ‘Multidisciplinary approaches to nutritional problems’. Rank Prize Lecture Global nutrition challenges for optimal health and well-being. Proc Nutr Soc 68, 34–42.
Uauy R, Dangour AD (2006). Nutrition in brain development and aging: role of essential fatty acids. Nutr Rev 64, S24–S33.
Uauy R, Hoffman DR (1991). Essential fatty acid requirements for normal eye and brain development. Semin Perinatol 15, 449–455.
Valsta LM, Tapanainen H, Sundvall J, Laatikainen T, Mannisto S, Pietinen P et al. (2010). Explaining the 25-year decline of serum cholesterol by dietary changes and use of lipid-lowering medication in Finland. Public Health Nutr 13, 932–938.
van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Dullemeijer C, Olderikkert MG et al. (2008). Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 71, 430–438.
Vartiainen E, Laatikainen T, Peltonen M, Juolevi A, Mannisto S, Sundvall J et al. (2010). Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 39, 504–518.
Viikari J, Akerblom HK, Seppanen A, Marniemi J, Sarna S (1988). Atherosclerosis precursors in Finnish children and adolescents—serum lipids, tracking of serum lipids, and preliminary results from cluster analyses of risk factors. Prog Clin Biol Res 255, 81–87.
Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B et al. (2006). n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84, 5–17.
Webber LS, Srinivasan SR, Wattigney WA, Berenson GS (1991). Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa heart study. Am J Epidemiol 133, 884–899.
Wendland E, Farmer A, Glasziou P, Neil A (2006). Effect of alpha linolenic acid on cardiovascular risk markers: a systematic review. Heart 92, 166–169.
WHO/FAO (2003). Diet, Nutrition and the Prevention of Chronic Diseases: Report of a Joint WHO/FAO Expert Consultation. WHO Technical Report Series No. 916. World Health Organization: Geneva.
World Cancer Research Fund/American Institute for Cancer Research (2007). Food, Nutrition, Physical Activity and the Prevention of Cancer. AICR: Washington DC.
World Health Organization (2010). Population-Based Strategies for Childhood Obesity: Report of the WHO Forum and Technical Meeting, Geneva, 15-17 December 2009. WHO: Geneva.
Yaqoob P, Calder PC (2007). Fatty acids and immune function: new insights into mechanisms. Br J Nutr 98 (Suppl 1), S41–S45.
Zatonski W, Campos H, Willett W (2008). Rapid declines in coronary heart disease mortality in Eastern Europe are associated with increased consumption of oils rich in alpha-linolenic acid. Eur J Epidemiol 23, 3–10.
Zhao G, Etherton TD, Martin KR, West SG, Gillies PJ, Kris-Etherton PM (2004). Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 134, 2991–2997.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
PCC, CD, BK, DM, HN and RU received an honorarium for their contributions to the symposium and the current paper from Unilever Netherlands BV. AE, GWM and SJMO are employees of Unilever. DM reports receiving research grants from GlaxoSmithKline, Sigma Tau, Pronova, and the National Institutes of Health for an investigator-initiated, not-for-profit clinical trial; travel reimbursement, honoraria, or consulting fees from the International Life Sciences Institute, Aramark, Unilever, SPRIM, and Nutrition Impact; and royalties from UpToDate for an online chapter. BK is the recipient of a Freedom to Discover Award of the Bristol Myers Squibb Foundation, New York, NY, USA. The other authors declare no other conflict of interest.
Rights and permissions
About this article
Cite this article
Calder, P., Dangour, A., Diekman, C. et al. Essential fats for future health. Proceedings of the 9th Unilever Nutrition Symposium, 26–27 May 2010. Eur J Clin Nutr 64 (Suppl 4), S1–S13 (2010). https://doi.org/10.1038/ejcn.2010.242
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2010.242
Keywords
This article is cited by
-
Combined choline and DHA supplementation: a randomized controlled trial
European Journal of Nutrition (2020)
-
The effect of perinatal fish oil supplementation on neurodevelopment and growth of infants: a randomized controlled trial
European Journal of Nutrition (2018)
-
Transport of long-chain polyunsaturated fatty acids in preterm infant plasma is dominated by phosphatidylcholine
European Journal of Nutrition (2018)
-
Choline and polyunsaturated fatty acids in preterm infants’ maternal milk
European Journal of Nutrition (2017)
-
Plasma phospholipids indicate impaired fatty acid homeostasis in preterm infants
European Journal of Nutrition (2014)